Thomas N. Kledal

1.3k total citations
16 papers, 984 citations indexed

About

Thomas N. Kledal is a scholar working on Epidemiology, Immunology and Oncology. According to data from OpenAlex, Thomas N. Kledal has authored 16 papers receiving a total of 984 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Immunology and 5 papers in Oncology. Recurrent topics in Thomas N. Kledal's work include Cytomegalovirus and herpesvirus research (11 papers), Herpesvirus Infections and Treatments (8 papers) and Chemokine receptors and signaling (5 papers). Thomas N. Kledal is often cited by papers focused on Cytomegalovirus and herpesvirus research (11 papers), Herpesvirus Infections and Treatments (8 papers) and Chemokine receptors and signaling (5 papers). Thomas N. Kledal collaborates with scholars based in Denmark, United Kingdom and United States. Thomas N. Kledal's co-authors include Thue W. Schwartz, Mette M. Rosenkilde, Annegret Pelchen–Matthews, Alberto Fraile‐Ramos, Mark Marsh, Maria Waldhoer, Helen E. Farrell, Katja Spieß, Katherine Bowers and Helena Browne and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Thomas N. Kledal

16 papers receiving 971 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas N. Kledal Denmark 15 623 353 288 247 100 16 984
Delu Zhou United States 12 253 0.4× 304 0.9× 47 0.2× 190 0.8× 56 0.6× 16 655
Kazushi Nakano Japan 14 544 0.9× 169 0.5× 474 1.6× 137 0.6× 45 0.5× 34 848
Monique W. Bruinsma United States 8 369 0.6× 277 0.8× 114 0.4× 459 1.9× 34 0.3× 9 934
Shaheen S. Sutterwala United States 9 260 0.4× 631 1.8× 186 0.6× 241 1.0× 25 0.3× 9 1.1k
Maciej T. Nogalski United States 14 671 1.1× 301 0.9× 74 0.3× 164 0.7× 181 1.8× 19 864
Suzu Igarashi United States 11 320 0.5× 308 0.9× 45 0.2× 251 1.0× 30 0.3× 16 849
Heesoon Chang United States 13 779 1.3× 202 0.6× 717 2.5× 310 1.3× 67 0.7× 19 1.2k
Mohammed Oukka United States 9 200 0.3× 852 2.4× 163 0.6× 266 1.1× 66 0.7× 10 1.2k
Marjon Navis Netherlands 19 329 0.5× 870 2.5× 230 0.8× 204 0.8× 16 0.2× 27 1.3k
Julie A. Kerry United States 16 415 0.7× 163 0.5× 128 0.4× 265 1.1× 133 1.3× 29 699

Countries citing papers authored by Thomas N. Kledal

Since Specialization
Citations

This map shows the geographic impact of Thomas N. Kledal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas N. Kledal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas N. Kledal more than expected).

Fields of papers citing papers by Thomas N. Kledal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas N. Kledal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas N. Kledal. The network helps show where Thomas N. Kledal may publish in the future.

Co-authorship network of co-authors of Thomas N. Kledal

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas N. Kledal. A scholar is included among the top collaborators of Thomas N. Kledal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas N. Kledal. Thomas N. Kledal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Krishna, Benjamin A., Katja Spieß, Emma Poole, et al.. (2017). Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein. Nature Communications. 8(1). 14321–14321. 53 indexed citations
3.
Spieß, Katja, et al.. (2017). Novel Chemokine-Based Immunotoxins for Potent and Selective Targeting of Cytomegalovirus Infected Cells. Journal of Immunology Research. 2017. 1–12. 23 indexed citations
4.
Spieß, Katja, et al.. (2016). The future of antiviral immunotoxins. Journal of Leukocyte Biology. 99(6). 911–925. 24 indexed citations
5.
Spieß, Katja, Mads Gravers Jeppesen, Karen Krzywkowski, et al.. (2015). Rationally designed chemokine-based toxin targeting the viral G protein-coupled receptor US28 potently inhibits cytomegalovirus infection in vivo. Proceedings of the National Academy of Sciences. 112(27). 8427–8432. 39 indexed citations
6.
Hjortø, Gertrud M., et al.. (2013). Human cytomegalovirus chemokine receptor US28 induces migration of cells on a CX3CL1-presenting surface. Journal of General Virology. 94(5). 1111–1120. 19 indexed citations
7.
Farrell, Helen E., Rhonda D. Cardin, Alexander H. Sparre‐Ulrich, et al.. (2011). Partial Functional Complementation between Human and Mouse Cytomegalovirus Chemokine Receptor Homologues. Journal of Virology. 85(12). 6091–6095. 36 indexed citations
8.
Hjortø, Gertrud M., Morten Hansen, Niels B. Larsen, & Thomas N. Kledal. (2009). Generating substrate bound functional chemokine gradients in vitro. Biomaterials. 30(29). 5305–5311. 14 indexed citations
9.
Rosenkilde, Mette M. & Thomas N. Kledal. (2006). Targeting Herpesvirus Reliance of the Chemokine System. Current Drug Targets. 7(1). 103–118. 19 indexed citations
10.
Casarosa, Paola, Maria Waldhoer, Patricia J. LiWang, et al.. (2004). CC and CX3C Chemokines Differentially Interact with the N Terminus of the Human Cytomegalovirus-encoded US28 Receptor. Journal of Biological Chemistry. 280(5). 3275–3285. 66 indexed citations
11.
Waldhoer, Maria, Thomas N. Kledal, Helen E. Farrell, & Thue W. Schwartz. (2002). Murine Cytomegalovirus (CMV) M33 and Human CMV US28 Receptors Exhibit Similar Constitutive Signaling Activities. Journal of Virology. 76(16). 8161–8168. 138 indexed citations
12.
Fraile‐Ramos, Alberto, Annegret Pelchen–Matthews, Thomas N. Kledal, et al.. (2002). Localization of HCMV UL33 and US27 in Endocytic Compartments and Viral Membranes. Traffic. 3(3). 218–232. 128 indexed citations
13.
Fraile‐Ramos, Alberto, Thomas N. Kledal, Annegret Pelchen–Matthews, et al.. (2001). The Human Cytomegalovirus US28 Protein Is Located in Endocytic Vesicles and Undergoes Constitutive Endocytosis and Recycling. Molecular Biology of the Cell. 12(6). 1737–1749. 153 indexed citations
14.
Mizoue, Laura S., Susan K. Sullivan, David S. King, et al.. (2001). Molecular Determinants of Receptor Binding and Signaling by the CX3C Chemokine Fractalkine. Journal of Biological Chemistry. 276(36). 33906–33914. 38 indexed citations
15.
Giwercman, Aleksander, Thomas N. Kledal, Marianne Schwartz, et al.. (2000). Preserved Male Fertility Despite Decreased Androgen Sensitivity Caused by a Mutation in the Ligand-Binding Domain of the Androgen Receptor Gene1. The Journal of Clinical Endocrinology & Metabolism. 85(6). 2253–2259. 45 indexed citations
16.
Kledal, Thomas N., Mette M. Rosenkilde, & Thue W. Schwartz. (1998). Selective recognition of the membrane‐bound CX3C chemokine, fractalkine, by the human cytomegalovirus‐encoded broad‐spectrum receptor US28. FEBS Letters. 441(2). 209–214. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026